Log in or Sign up for Free to view tailored content for your specialty!
Obesity News
Finerenone improves outcomes in patients with mildly reduced, preserved ejection fraction
In patients with heart failure and mildly reduced or preserved ejection fraction, finerenone reduced risk for CV death and worsening HF by 16% compared with placebo, researchers reported at the European Society of Cardiology Congress.
Wegovy linked to fewer COVID-19-related deaths vs. placebo in SELECT population
In an analysis of deaths of patients with obesity but not diabetes from the SELECT trial, those assigned semaglutide 2.4 mg had reduced risk for death from COVID-19 compared with those assigned placebo.
Log in or Sign up for Free to view tailored content for your specialty!
Less than 1% of Military Health System beneficiaries use an obesity medication
Obesity medications were prescribed to very few Military Health System beneficiaries between October 2017 and September 2022, according to a study published in Obesity.
Choosing the right medication for obesity treatment: Factors to consider
Managing obesity involves a well-rounded approach, often including lifestyle modifications and, in many cases, pharmacotherapy. Understanding the role of anti-obesity medications is crucial in this context.
Wegovy likely not cost-effective in the SELECT trial population
Researchers estimate that semaglutide 2.4 mg is not cost-effective for secondary CVD prevention for patients with overweight or obesity without diabetes, according to an Australian study.
Intermittent fasting bests standard diet in lowering liver fat content in MASLD, obesity
An intermittent calorie restriction diet was “safe and more effective” in reducing hepatic steatosis at 12 weeks vs. a standard of care diet in metabolic dysfunction-associated steatotic liver disease, particularly among those with obesity.
GLP-1s may improve outcomes when added to SGLT2 therapy for HFpEF, diabetes and obesity
GLP-1 receptor agonist use on top of SGLT2 inhibition in patients with HF with preserved ejection fraction, type 2 diabetes and obesity was associated with reduced risk for adverse events vs. SGLT2 inhibition alone, researchers reported.
Q&A: Overlooked health issues that ‘need to be addressed’ in Asian communities
Asian American, Native Hawaiian and Pacific Islander, or AA and NH/PI, communities continue to face significant racial disparities in health care access and outcomes across the United States, according to an expert.
Risk for pediatric atopic dermatitis rises with weight gain, drops with weight loss
Gaining weight can raise the risk for atopic dermatitis and possibly other immune-mediated skin diseases in children, whereas losing weight can reduce this risk, according to a study.
Single-dose vials of tirzepatide now available on LillyDirect for adults with obesity
Adults with obesity who have been prescribed tirzepatide can now purchase 2.5 mg and 5 mg single-dose vials of the medication, Eli Lilly announced.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read